‘ Forever Chemical ’ Lawsuits Could Ultimately Eclipse the Big Tobacco Settlement
It was the dead cows on Wilbur Tennant’s farm that shaped most of Rob Bilott’s professional life. Tennant’s farm was located in Parkersburg, W. Va.; Bilott was—and remains—an environmental lawyer at the firm of Taft Stettinius & Hollister in Cincinnati. All had been well for Tennant until 1998, when half of his herd of 300 cows began to languish and die. The farmer and the lawyer never would have come together, but Bilott’s grandmother lived near Tennant, and a mutual friend suggested Tennant call her grandson for counsel.
Tennant had reason to suspect he needed the help of an envir...
Source: TIME: Science - July 12, 2023 Category: Science Authors: Jeffrey Kluger Tags: Uncategorized Environment healthscienceclimate Source Type: news
Drug Trials Snapshot: FOTIVDA
FOTIVDA is a prescription medicine used to treat adult patients with advance kidney cancer (advanced renal cell carcinoma or RCC) that has been treated with 2 or more prior medicines and has come back or did not respond to treatment. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - July 6, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Urology: towards better care for patients with kidney cancer
Getting It Right First Time -This guidance – a collaboration between Getting It Right First Time, the British Association of Urological Surgeons and the British Association of Urological Nurses – describes the key features of a good kidney cancer service and lists the quality actions teams can take to bridge any gaps they identify. It al so includes a delivery checklist and case studies illustrating good practice.GuidanceGetting It Right First Time - publications (Source: The Kings Fund - Health Management Specialist Collection)
Source: The Kings Fund - Health Management Specialist Collection - July 6, 2023 Category: Health Management Authors: The King ' s Fund Library Tags: Patient involvement, experience and feedback Quality of care and clinical outcomes Source Type: news
S2 Episode 4: Renal Cell Carcinoma and Quality-of-Life Research S2 Episode 4: Renal Cell Carcinoma and Quality-of-Life Research
Drs Sumanta Pal and Sarah P. Psutka discuss the current quality-of-life research in bladder cancer, prehabilitation practices, helpful technology, and how this can be applied to renal cell carcinoma.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 5, 2023 Category: Consumer Health News Tags: Urology InDiscussion Source Type: news
PET/CT radiomics help with multiple myeloma prognosis
Radiomics models based on F-18 FDG-PET/CT imaging features and powered by machin...Read more on AuntMinnie.comRelated Reading:
SNMMI: Experts debate AI's role in nuclear medicine
PET/CT shows value in patients with portal vein thrombosis
SNMMI: PET tracer describes clear cell renal cancer
SNMMI: New technology improves whole-body PET image quality
PET predicts 'dry mouth' side effect in radiotherapy patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 30, 2023 Category: Radiology Source Type: news
Video from SNMMI: Sutcliffe discusses findings in Image of the Year
CHICAGO - In an interview at the Society of Nuclear Medicine and Molecular Imagin...Read more on AuntMinnie.comRelated Reading:
SNMMI: Experts debate AI's role in nuclear medicine
SNMMI: PET tracer describes clear cell renal cancer
SNMMI: New therapeutic target discovered for bladder cancer
SNMMI Image of the Year shows potential for pancreatic cancer theranostics
SNMMI: New theranostics pair shows promise in pancreatic cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 28, 2023 Category: Radiology Source Type: news
SNMMI bestows inaugural transformational leadership award
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has bestowed it...Read more on AuntMinnie.comRelated Reading:
SNMMI: PET tracer describes clear cell renal cancer
SNMMI: New therapeutic target discovered for bladder cancer
SNMMI: PET tracer model quantifies cardiac amyloidosis burden
SNMMI Image of the Year shows potential for pancreatic cancer theranostics
SNMMI and IAC collaborate on accreditation program (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 27, 2023 Category: Radiology Source Type: news
SNMMI inducts 2023 fellows
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) recognized nin...Read more on AuntMinnie.comRelated Reading:
SNMMI: PET tracer describes clear cell renal cancer
SNMMI: New therapeutic target discovered for bladder cancer
SNMMI: PET tracer model quantifies cardiac amyloidosis burden
SNMMI Image of the Year shows potential for pancreatic cancer theranostics
SNMMI and IAC collaborate on accreditation program (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 27, 2023 Category: Radiology Source Type: news
Highlights in Renal Cell Carcinoma From ASCO 2023 Highlights in Renal Cell Carcinoma From ASCO 2023
Data on combination therapies, real-world findings on TKIs, and 4-year follow-up of the CLEAR study are among the highlights in renal cell carcinoma from ASCO 2023, as reported by Dr Eric Jonasch.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 27, 2023 Category: Consumer Health News Tags: None ReCAP Source Type: news
SNMMI: PET tracer model quantifies cardiac amyloidosis burden
A tracer kinetic model can enable quantitative measurement of cardiac amyloidosi...Read more on AuntMinnie.comRelated Reading:
SNMMI: PET tracer describes clear cell renal cancer
SNMMI Image of the Year shows potential for pancreatic cancer theranostics
SNMMI and IAC collaborate on accreditation program
PET tracer images brain cholesterol metabolism
Tau PET best for imaging Alzheimer's disease progression (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 27, 2023 Category: Radiology Source Type: news
SNMMI: PET tracer describes clear cell renal cancer
A new PET tracer can accurately detect and differentiate a certain type of kidne...Read more on AuntMinnie.comRelated Reading:
SNMMI Image of the Year shows potential for pancreatic cancer theranostics
PET tracer images brain cholesterol metabolism
SNMMI: PET leads in developing new breast cancer therapy
SNMMI: New theranostics pair shows promise in pancreatic cancer
SNMMI: New technology improves whole-body PET image quality (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 26, 2023 Category: Radiology Source Type: news
Scientists Say They ’ve Reached ‘Turning Point’ in Cancer Research With Vaccines
SEATTLE — The next big advance in cancer treatment could be a vaccine.
After decades of limited success, scientists say research has reached a turning point, with many predicting more vaccines will be out in five years.
These aren’t traditional vaccines that prevent disease, but shots to shrink tumors and stop cancer from coming back. Targets for these experimental treatments include breast and lung cancer, with gains reported this year for deadly skin cancer melanoma and pancreatic cancer.
“We’re getting something to work. Now we need to get it to work better,” said Dr. James Gulley, who help...
Source: TIME: Health - June 26, 2023 Category: Consumer Health News Authors: Carla K. Johnson / AP Tags: Uncategorized Cancer wire Source Type: news
Scientists Say They ’ve Reached Turning Point in Cancer Research With Vaccines
SEATTLE — The next big advance in cancer treatment could be a vaccine.
After decades of limited success, scientists say research has reached a turning point, with many predicting more vaccines will be out in five years.
These aren’t traditional vaccines that prevent disease, but shots to shrink tumors and stop cancer from coming back. Targets for these experimental treatments include breast and lung cancer, with gains reported this year for deadly skin cancer melanoma and pancreatic cancer.
More from TIME
[video id=W5jcvwLu autostart="viewable"]
“We’re getting something to work. Now we need to get...
Source: TIME: Health - June 26, 2023 Category: Consumer Health News Authors: Carla K. Johnson / AP Tags: Uncategorized Cancer wire Source Type: news
Telix to acquire Lightpoint Medical for $20M
Telix Pharmaceuticals has entered a $20 million agreement to acquire th...Read more on AuntMinnie.comRelated Reading:
First patient dosed in phase II Telix Starburst trial
Telix acquires Dedicaid for $1.2M
Telix gets FDA nod for gallium injection prep kit
Telix makes two new executive appointments
Telix highlights kidney cancer imaging study results (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 21, 2023 Category: Radiology Source Type: news
First patient dosed in phase II Telix Starburst trial
The first patient has been dosed in Telix Pharmaceuticals' carbonic anhydrase-targetin...Read more on AuntMinnie.comRelated Reading:
Telix acquires Dedicaid for $1.2M
Telix gets FDA nod for gallium injection prep kit
Telix makes two new executive appointments
Telix highlights kidney cancer imaging study results
Telix relocates U.S. headquarters (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 19, 2023 Category: Radiology Source Type: news
